Forecast: Calcium Channel Blocking Medicine Use in Canada

The usage of calcium channel blocking medicine in Canada is projected to increase consistently from 2024 through 2028, growing from 71.8 units to 80.4 units per thousand persons per day. This forecast indicates a steady growth pattern with year-on-year percentage increases approximately ranging from 3% to 3.5%. Given this trend, the compound annual growth rate (CAGR) over the five-year period from 2024 to 2028 is anticipated to be around 3.1%. This suggests a robust demand for these medications, influenced likely by an aging population and the prevalence of cardiovascular diseases.

Future trends to watch for include advancements in medical technology that may improve treatment options, potential regulatory changes affecting drug prescribing practices, and emerging competition from alternative treatments that could impact the forecasted growth of calcium channel blockers usage.